-
Categories
-
Technology, Healthcare & Medical
-
Min Investment
-
$100
-
No. Investors
-
96
Key Deal Facts
Repeat hardtech entrepreneur founders; former professors at MIT and Rice University.
Backed by top Venture Capitalists and top industry experts.
Portfolio of 12 pending patents on both AI and Bio.
Over 8000 biological/clinical samples analyzed with proprietary RNAseq and AI technologies.
Clinical collaborations with top hospitals including Harvard Med School, MD Anderson, and Cornell.
Subsidiaries in Bangalore, India and Shanghai, China.
Management Team / Advisory Board Bios
Dave Zhang Co-Founder/CEO• Former co-founder/CEO of Nuprobe, raised $110M venture funding
• Former professor of Bioengineering at Rice University
• 2019 Presidential Early Career Award in Science and Engineering
• scholar.google.com/citations?user=q3sWmXUAAAAJ, Ashwin Gopinath Co-Founder/CTO• Former professor of Mech. Engineering at MIT
• Former co-founder/CTO of Palamedrix, acquired for $50M+
• Former Fellow at Google X
• scholar.google.com/citations?user=Q3kRJj4AAAAJ, Paul Rothemund VP of Research• Former professor of Computational and Neural Systems at Caltech
• Former co-founder/CSO of Palamedrix, acquired for $50M+.
• 2007 MacArthur Fellow
• scholar.google.com/citations?user=MnQWxDEAAAAJ, Eva Miao Head of Operations• Former CFO of Torus Biosystems
• Former VP Finance of Proven Skincare
• Former Head of FP&A at Genuity/WuXi Apptec, Timothy Kassis Head of AI• Former Head of AI of Matterworks
• Former Lead Instructor at MIT
• scholar.google.com/citations?user=RnNkFJ1cZp4C&hl